A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Akeso
Related studies linked through entity extraction aliases.
Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Long-term Study of AK102 in Patients With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of PCSK9 Inhibitor AK102 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2